BioDiem Ltd. (BDM.AX)
-ASX | Prev Close: | 0.04 |
|---|
| Open: | 0.04 |
|---|
| Bid: | 0.03 |
|---|
| Ask: | 0.04 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.04 - 0.04 |
|---|
| 52wk Range: | 0.03 - 0.07 |
|---|
| Volume: | 107,030 |
|---|
| Avg Vol (3m): | 29,339 |
|---|
| Market Cap: | 4.97M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in AUD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 6.34 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
BioDiem Ltd, a biotechnology company, engages in the discovery, development, and commercialization of research and technology for infectious diseases and related cancers.
View More